FIMM has close connections to the Helsinki University Hospital and extensive experience with deep molecular profiling and machine-assisted analysis of patient samples. In recent years we have established collaborative research projects with several pharmaceutical partners. In this webinar, we will feature our collaboration with Novartis.
Date and time:
June 22, 16:00 - 17:30 EEST (Helsinki)
The webinar will be organized via Zoom.
Speakers:
Research Director Caroline Heckman (FIMM), Professor Kimmo Porkka (HUS), and VP, Global Head of Biomarker & Diagnostic Celine Pallaud (Novartis)
Programme:
16.00-16.05: Welcome and introduction to FIMM's Functional Precision Medicine in Cancer Grand Challenge Programme
Dr. Caroline Heckman, Research Director, FIMM, University of Helsinki
16.05-16.20: Precision medicine in practice: Helsinki hematology experience
Professor Kimmo Porkka, Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center
16.20-16.35: Correlative studies in hematology for biomarker discovery
Dr. Caroline Heckman, Research Director, FIMM, University of Helsinki
16.35-16.50: Advancing precision medicine through industry-academic partnerships
Dr. Celine Pallaud, VP, Global Head of Biomarker & Diagnostic, Novartis
16:50-17:05 Q/A and discussion
17:05-17:30 Possibility to join breakout rooms hosted by our speakers and FIMM technology and administrative experts to ask questions and/or learn more about the following themes:
- Translating research to patient care
- Applying FIMM technologies for precision medicine: Single cell analytics
- Applying FIMM technologies for precision medicine: Drug sensitivity testing
- Examples of blood cancer research to advance precision medicine
- Legal challenges and administrative aspects of establishing collaborations between industry and academic researchers
